AAPS Webinar Proposal Submission Form
Instructions:
Please note that forms will be immediately rejected unless all requested information is complete.
1. Please complete this form in its entirety by placing your cursor in the gray boxes and typing the information.
2. There is an example of an appropriately completed form on pages 4-6 for your reference.
3. Save the completed form on your desktop and then submit by emailing as an attachment to the addresses
shown at the bottom of the form.
This form will be submitted to the AAPS Electronic Program Development Committee (EPDC) for review and
their feedback will be sent back to you promptly.
Your Section or Focus Group:
Do you have the support of your Section or Focus Group leadership as each group has a finite
number of allotted webinars per year? ____Yes ____No
Proposed Webinar Title:
Primary Webinar Organizer (that is probably you):
Name:
Company:
Phone:
Email:
Webinar Presenter #1:
Name:
Company:
Phone:
Email:
Webinar Presenter #2 (optional):
Name:
Company:
Phone:
Email:
Webinar Moderator:
Name:
Company:
Phone:
Email:
Program Objectives: (in bullet point format, outlining the topics to be discussed)
Abstract: (175 word minimum)
Who will benefit most from this webinar?
Please check the gray boxes for all relevant sections, words, and terms applicable to the proposed webinar.
The items you check will be used to index your event listing on the AAPS website.
Analysis and Pharmaceutical Quality Section
Clinical Pharmacology and Translational
Research Section
Formulation Design and Development
Section
Physical Pharmacy and Biopharmaceutics
Section
Regulatory Sciences Section
ADME
Analytical Method Development
Animal Welfare
Bioequivalence
Biopharmaceutics
Biopharmaceutics Classification System
Biotechnology
Chromatography
Biotechnology Section
Drug Design and Discovery Section
Manufacturing Science and Engineering
Section
Pharmacokinetics, Pharmacodynamics and
Drug Metabolism Section
Forced Degradation
Formulation
Formulation Design and Development
Freezing and Drying Technologies
Guidance on Drug Interactions
Hot Melt Extrusion
HPLC
Human Cytochromes P450
Clinical Trials
Combination Products
Compliance Trends
Continuous Process
Delivery
Discovery
Drug Delivery
Drug Disposition
Drug Manufacturing
Drug Transport
Fluid Drying
Excipients
Fluid Drying
ICH Q8- Q9- Q10
Immunogenicity
In Vitro Release and Dissolution Testing
IND
Inhalation and Nasal Technology
Manufacturing
Mass Spectrometry
Modified Release
Nanotechnology
NDA
Non-Clinical Dose Formulation Analysis
PAT
Pharmaceutical Manufacturing
Please enter below any other terms NOT listed above that can be used as search terms. Please do NOT
include terms or words used in any titles or description of your event.
Enter Keywords:
Please review this proposal with your presenter(s). It will be the basis for the webinar brochure.
Send your presenter and moderator the Webinar Guidelines
Send your presenter the Speaker Release Form
Email completed form to: Stacey May, Director of Public Relations, Outreach, and eLearning, and send
a copy to: Meredith Weston, eLearning Program Manager WestonM@aaps.org
EPDC-approved webinars are scheduled on a first-come, first-served basis.
EXAMPLE OF AN APPROPRIATE WEBINAR SUBMISSION
Your Section or Focus Group:
Discovery Modeling and Simulation Focus Group and DDDI
Do you have the support of your Section or Focus Group leadership as each group has a finite
number of allotted webinars per year? _X_Yes ____No
Proposed Webinar Title:
In Silico Tools in Preformulation and Formulation Development
Name:
Company:
Phone:
Email:
Primary Webinar Organizer (that is probably you):
Jane Smith
Concordia University Wisconsin
555-555-5555
jane@cuw.edu
Name:
Company:
Phone:
Email:
Webinar Presenter #1:
John White
Merck & Co., Inc.
555-555-5555
jwhite@merck.com
Name:
Company:
Phone:
Email:
Name:
Company:
Phone:
Email:
Webinar Presenter #2 (optional):
n/a
Webinar Moderator:
Chris Brown
Genentech, Inc.
555-555-5555
brownck@gene.com
Program Objectives: (in bullet point format, outlining the topics to be dicussed)



Predicting and Optimizing Physical Properties
- Prediction of PhysChem properties
- Optimization of properties at the design stage. SPR approaches
- Correlation between physical attributes and ADME properties
Absorption and Formulation Modeling
- Simple absorption models and application for preclinical studies
- Leveraging commercial software packages
BCS and BDDCS Predictions
- Predictions of solubility, permeability, and metabolism to forecast regulatory risks
Abstract: (175 word minimum)
The formulation of a drug can impact its route and frequency of administration, its ADME and safety
profiles as well as its shelf-life. The preformulation development and characterization of the
physicochemical properties of a drug candidate provide the basis for the selection of suitable preclinical
or clinical formulations. Properties such as molecular weight, pKa, log D7, solubility and particle size can
affect drug absorption and bioperformance. However, most of these properties are commonly
experimentally measured to determine a formulation strategy, which requires a significant amount of
time and resource investment. Accurate prediction of these properties would preclude the need for
experimental assessment. Thorough understanding of the physicochemical properties can then
accelerate formulation development, optimize bioperformance, and reduce timelines and risks
associated with drug candidates development. In silico approaches have the promise for guiding and
enabling rapid formulation selection at an early stage.
This webinar will summarize efforts made around the prediction of physicochemical properties of
molecules and modeling of the absorption and bioperformance of drug candidates, and will describe
how this information can be used to reduce the risks present in drug development.
Who will benefit most from this webinar?
Industry scientists seeking to gain an understanding of the utility of current in silico modeling
approaches and applications towards the characterization and formulation development of new drug
candidates. Academic scientists with interests in translation of drug discovery and into preclinical
development.
Please check the gray boxes for all relevant sections, words, and terms applicable to the proposed webinar.
The items you check will be used to index your event listing on the AAPS website.
X
X
X
X
X
Analysis and Pharmaceutical Quality Section
Clinical Pharmacology and Translational
Research Section
Formulation Design and Development
Section
Physical Pharmacy and Biopharmaceutics
Section
Regulatory Sciences Section
ADME
Analytical Method Development
Animal Welfare
Bioequivalence
Biopharmaceutics
Biopharmaceutics Classification System
Biotechnology
Chromatography
Clinical Trials
Combination Products
Compliance Trends
Continuous Process
Biotechnology Section
X
Drug Design and Discovery Section
Manufacturing Science and Engineering
Section
Pharmacokinetics, Pharmacodynamics and
Drug Metabolism Section
X
X
Forced Degradation
Formulation
Formulation Design and Development
Freezing and Drying Technologies
Guidance on Drug Interactions
Hot Melt Extrusion
HPLC
Human Cytochromes P450
ICH Q8- Q9- Q10
In Vitro Release and Dissolution Testing
IND
Inhalation and Nasal Technology
X
Delivery
Discovery
Drug Delivery
Drug Disposition
Drug Manufacturing
Drug Transport
Fluid Drying
Excipients
Fluid Drying
Manufacturing
Mass Spectrometry
Modified Release
Nanotechnology
NDA
Non-Clinical Dose Formulation Analysis
PAT
Pharmaceutical Manufacturing
Please enter below any other terms NOT listed above that can be used as search terms. Please do NOT
include terms or words used in any titles or description of your event.
Enter Keywords:
Preclinical modeling, simulation, computational tools, BCS, BDDCS
Please review this proposal with your presenter(s). It will be the basis for the webinar brochure.
Send your presenter and moderator the Webinar Guidelines
Send your presenter the Speaker Release Form
Email completed form to: Stacey May, Director of Public Relations, Outreach, and eLearning, and send
a copy to: Meredith Weston, eLearning Program Manager WestonM@aaps.org
EPDC-approved webinars are scheduled on a first-come, first-served basis.